INKON Life Technology Co Ltd
SZSE:300143
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
INKON Life Technology Co Ltd
Operating Expenses
INKON Life Technology Co Ltd
Operating Expenses Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
INKON Life Technology Co Ltd
SZSE:300143
|
Operating Expenses
-¥302.3m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-15%
|
|
|
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
Operating Expenses
-¥5.8B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-20%
|
|
|
I
|
Innovative Medical Management Co Ltd
SZSE:002173
|
Operating Expenses
-¥107.9m
|
CAGR 3-Years
8%
|
CAGR 5-Years
37%
|
CAGR 10-Years
-7%
|
|
|
X
|
XiAn International Medical Investment Co Ltd
SZSE:000516
|
Operating Expenses
-¥568.8m
|
CAGR 3-Years
5%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-3%
|
|
|
H
|
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
|
Operating Expenses
-¥1.2B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sanbo Hospital Management Group Ltd
SZSE:301293
|
Operating Expenses
-¥193.1m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
INKON Life Technology Co Ltd
Glance View
INKON Life Technology Co., Ltd. engages in the research, development, production and sale of edible fungus. The company is headquartered in Qingdao, Shandong and currently employs 1,791 full-time employees. The company went IPO on 2011-04-22. Its medical services focus on cancer prevention, diagnosis, treatment and rehabilitation. The firm is also engaged in the research and development, manufacture and sales of medical equipment, as well as medical software development. Its medical equipment mainly include MASEP digital radiotherapy equipment, MASEP Gamma Knife and other large medical equipment. The firm distributes its products within domestic market and to overseas markets.
See Also
What is INKON Life Technology Co Ltd's Operating Expenses?
Operating Expenses
-302.3m
CNY
Based on the financial report for Dec 31, 2025, INKON Life Technology Co Ltd's Operating Expenses amounts to -302.3m CNY.
What is INKON Life Technology Co Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-15%
Over the last year, the Operating Expenses growth was -14%. The average annual Operating Expenses growth rates for INKON Life Technology Co Ltd have been -16% over the past three years , -16% over the past five years , and -15% over the past ten years .
